Andre ten Haaf

NFATc1 as a therapeutic target in FLT3-ITD-positive AML

Stephan Metzelder, Christian Michel, Malte von Bonin et al. · Leukemia · 2015 · 51 citations · Full text

Medicine, Biomarker Target, Immunology +5

The 140-kD Isoform of CD56 (NCAM1) Directs the Molecular Pathogenesis of Ischemic Cardiomyopathy

Mehmet Kemal Tur, Benjamin Etschmann, Alexander Benz et al. · American Journal Of Pathology · 2013 · 26 citations

Cardiac Muscle, Cardiomyopathy, Heart Failure +12

Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia

Jenny Fitting, Tobias Blume, Andre ten Haaf et al. · mAbs · 2015 · 23 citations · Full text

Immunology, Antibody Fragments, Immunotherapeutics +22

In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells

Judith Niesen, Hannes Brehm, Christoph Stein et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 21 citations · Full text

Tumor Biology, Egfr-specific Immunotoxin, Cancer Immunosurveillance +11

Development of a monoclonal sandwich ELISA for direct detection of bluetongue virus 8 in infected animals

Andre ten Haaf, Johannes Kohl, Sibylle Pscherer et al. · Journal of Virological Methods · 2017 · 18 citations

Diagnostic Virology, Viral Diagnostics, Pathogenesis +10